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There has been a surge of interest in recent years in incorporating genetic components into 
on‑going longitudinal, developmental studies and related psychological studies. While this 
represents an exciting new direction in developmental science, much of the research on genetic 
topics in developmental science does not reflect the most current practice in genetics. This is 
likely due, in part, to the rapidly changing landscape of the field of genetics, and the difficulty 
this presents for developmental scientists who are trying to learn this new area. In this review, 
we present an overview of the paradigm shifts that have occurred in genetics and we introduce 
the reader to basic genetic methodologies. We present our view of the current stage of research 
ongoing at the intersection of genetics and social science, and we provide recommendations 
for how we could do better. We also address a number of issues that social scientists face as 
they integrate genetics into their projects, including choice of a study design (candidate gene 
versus genome‑wide association versus sequencing), different methods of DNA collection, 
and special considerations involved in the analysis of genotypic data. Through this review, we 
hope to equip social scientists with a deeper understanding of the many considerations that 
go into genetics research, in an effort to foster more meaningful cross‑disciplinary initiatives.
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genetic influences on behavior required special study designs 
and methodologies not widely employed by the broader psycho-
logical or developmental community. All this has changed now 
that it is possible to genotype specific genes and incorporate this 
information into any on-going study. This has made genetics 
accessible to mainstream developmental science. This molecular 
advance occurred in concert with growing recognition by social 
scientists of the importance of genetic predispositions. As behav-
ior genetic studies increasingly acknowledged the complexity of 
genetic influences on behavior – that genes are not destiny; that 
genetic effects are dynamic, changing across development and 
in conjunction with the environment – there was a newfound 
consilience between genetics and traditional developmental 
science. These practical and theoretical shifts have contributed 
to an exponential increase of studies that incorporate genetic 
components. Consider that a search for “genetics” in PsychNet 
yields 26,192 hits for the years 2000–2010, as compared to just 
7575 hits for 1990–1999, a more than three-fold increase! In 
fact, the >26,000 publications from the past decade account for 
nearly 60% of the total number of hits for “genetics” listed in 
the entirety of PsychNet.
While obtaining DNA and producing genotypes is now easy, 
doing the best and most current genetics research is not. Much of 
the research on genetic topics in developmental science does not 
reflect the latest developments or most current practice in genetics. 
This is likely a product of many factors. Many PIs on developmental 
projects do not have formal training in genetics. In addition, the 
techniques and practical methodology in genetics are in a period of 
particularly rapid change and it is difficult to stay abreast of what is 
considered state of the art. This is true even for specialists, so it is a 
IntroductIon
Recent years have been witness to a surge of interest in incorporat-
ing genetic components into on-going longitudinal developmental 
projects and related psychological studies. This has likely been a 
product of many factors: Genotyping costs have fallen rapidly, and 
numerous commercial options for obtaining genotypes are avail-
able. It is increasingly easy to obtain DNA, with options such as 
cheek swab and saliva sample kits being commercially marketed 
and low burden on participants. Further, there has been rapid 
growth in the field of genetics. The revolutions and advances that 
the field has experienced in recent years have brought genetics to the 
forefront of science. Media attention to these advances, including 
the highly publicized mapping of the human genome, has raised 
public awareness about the importance of genetics. Genetics has 
been at the center of major NIH funding initiatives, and the cur-
rent Director of NIH, Francis Collins, is the former Director of the 
Human Genome Project.
Developmental science has not been immune to this revo-
lution. In contrast to the field of ethology, which has a rich 
tradition of examining of the genetic underpinnings of innate 
animal behavior (i.e., instincts), the study of genetic influences 
on human behavior was originally limited to the fledgling field 
of behavior genetics, which met with great resistance for arguing 
that behaviors widely “known” to have environmental etiologies 
(e.g., schizophrenia was caused by bad parenting) were under 
genetic influence. But genetic influences were not measured in 
these early behavior genetic studies, rather, they were inferred 
using family, twin, and adoption designs, by testing for similar-
ity across different types of relatives with different degrees of 
genetic and environmental overlap. This meant that to study 
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est. Highly polymorphic genetic markers (those having many alle-
les) were genotyped across the genome. Usually around 400 of 
these highly variable markers were genotyped across the genome. 
The basic technique compared whether affected individuals in a 
family were more likely than expected by chance to carry the same 
version of that genetic marker. If so, this suggested that there was 
a gene (or genes) in that chromosomal region that was related to 
susceptibility for the disorder. Ming Tsuang, a senior leader in 
the field of psychiatric genetics, once gave the analogy that gene 
finding is like hunting for a criminal. You start out with the entire 
world (genome) to search in order to find your criminal (gene). 
Finding linkage to a particular chromosomal region is like some-
one giving you a zip code in which your criminal resides – you 
still do not know exactly where he is; you still have a lot of houses 
to search (individual genes in the linkage region) before you find 
him (the susceptibility gene). But when you started out with the 
world, narrowing it down to a zipcode is an exciting step forward 
in the search!
We review this methodology here for sake of completeness, as 
it dominated the field of genetics for many years. It is now recog-
nized that linkage analyses were underpowered to detect common 
alleles with small individual effects on the outcome of interest. 
Although rare alleles with larger effects do seem likely to contrib-
ute to some common diseases, common alleles of small effect are 
generally believed to constitute the genetic influences on most com-
plex behavioral outcomes. However, the use of linkage evidence in 
conjunction with other kinds of genetic evidence has proven to be 
a useful strategy in gene identification in some projects (Dick and 
Bierut, 2006). There are situations where linkage analyses may be 
more powerful than association analyses (discussed below), such as 
when many different alleles (e.g., individual disease-predisposing 
or causal mutations) are present in a single gene. In addition, link-
age analyses may have some utility for finding the rare variants 
mentioned above. It remains to be seen whether multiply affected 
families have substantially different kinds of genetic risks than 
unselected cases from the population.
AssocIAtIon
Association analyses are the methods most commonly employed 
in gene identification efforts today, and the methodology that 
has been widely incorporated into developmental research. 
Association analyses are straightforward to understand; they basi-
cally test whether a particular genetic variant is more likely to be 
found in affected individuals than in unaffected individuals (in a 
case–control design; Figure 1), or more likely to be transmitted 
to affected children (in family-based designs; though these are 
increasingly less common since population stratification concerns 
have been alleviated by genome-wide data, as described below). 
Association relies on genotyping genetic markers, in the same way 
that linkage analyses did. The major difference between linkage 
and association methods is that linkage is a within-family statis-
tic, whereas association is a between-family statistic. In linkage, 
this meant that the same marker had to be shared across affected 
members within a family, but it could be a different marker from 
one family to the next. Association analyses, on the other hand, 
require that it is the same marker that is shared across all affected 
individuals in the sample. Linkage analyses only point to a  general 
formidable challenge for individuals who are new to the area, and 
even within the field of genetics there are differences of opinion as 
to what strategies are best in a given situation.
In this paper, we provide a guide for how to do “good genet-
ics research.” The authors on this paper come from a diversity of 
backgrounds, with Danielle M. Dick trained in clinical psychology 
(behavior genetics) and statistical genetics, Shawn J. Latendresse 
trained in child development and statistics, and Brien Riley trained 
in molecular genetics; yet we all have interest in understanding how 
genetic and environmental influences impact behavioral outcomes, 
and we work together at an interdisciplinary institute that takes 
advantage of complementary expertise. We recognize that with 
the rapid pace at which genetics advances, this review is likely to 
become dated. However, we hope that our presentation of many 
of the basic tenets of genetics will give the reader an appreciation 
of the complex issues that surround studying genetic influences 
on behavior. We note that we refer alternately to “developmental 
scientists” or “psychologists” as our target audience for this review, 
but in actuality the information is relevant to any social scientist 
with interest in adding a genetic component to an on-going project.
This paper is organized into a variety of sections. We start by pre-
senting an introduction to the paradigm shifts that have occurred in 
genetics in the past decade, in an effort to provide some historical 
context of the field. We introduce the reader to the basic method-
ologies of both linkage and association and the advantages and 
disadvantages of each. This is not intended to be an exhaustive or 
thorough coverage of these methodologies, but rather a very basic 
overview of different strategies. More exhaustive books on these 
topics exist (Neale et al., 2008). We present our view of the current 
state of research ongoing at the intersection of genetics and social 
science, and we provide recommendations for how we could do 
better. We also address a number of issues that social scientists face 
as they integrate genetics into their projects, including choice of a 
study design (candidate gene versus genome-wide association ver-
sus sequencing), different methods of DNA collection, and special 
considerations involved in the analysis of genotypic data. Through 
this review, we hope to equip social scientists with a deeper under-
standing of the many considerations that go into genetics research, 
in an effort to foster more meaningful cross-disciplinary initiatives.
BAsIc GenetIc MethodoloGIes
Molecular genetic studies depend critically on genetic markers, sites 
in the human genome where the underlying DNA sequence varies 
between individuals. Genetic markers include sites where different 
numbers of repeated bases distinguish individuals and the allele 
is actually of different length (e.g., ACACAC versus ACACACAC), 
single bases which differ between individuals (e.g., a C on some 
chromosomes and a T on others), among many kinds of variation. 
Each different version of sequence at these sites is called an allele, 
and what molecular genetics generally seeks to do is to identify sites 
where alleles (and hence positions in the genome) co-occur with 
disease (or other trait measurement).
lInkAGe
The paradigm that originally dominated human gene finding 
efforts was that of linkage analyses. Linkage studies ascertained 
families with multiple members affected with the disorder of inter-
www.frontiersin.org May 2011 | Volume 2 | Article 17 | 3
Dick et al. Doing good genetics research
although there is not a perfect correspondence between distance 
and correlation. Some regions of the genome are more likely to 
have recombination events (these are called “hotspots”),  leading 
to lower levels of LD between nearby markers. Accordingly, some 
stretches of the genome have high LD occurring over long dis-
tances, whereas other regions of the genome have very low LD.
The existence of LD means that we do not actually have to 
genotype the causal locus to detect association; we simply have 
to genotype variation very near the causal locus. In practice, it is 
exceedingly difficult to determine whether an association signal 
results due to direct or indirect association, though the default 
assumption must be that it is indirect. First, most genetic vari-
ants (like the alleles of most markers we study) have no obvious 
functional significance. Only ∼2% of the genome represents genes, 
and the exons (segments of coding information) are interspersed 
with often much larger introns (segments within the gene that 
do not carry coding information) so only ∼1% of the DNA in the 
genome actually codes for functional molecules. Thus, the chance of 
a variant impacting the function of a key molecule is small. Second, 
this difficulty is compounded by the expectation that most of the 
alleles influencing traits common in the population are common 
and of relatively small effect (i.e., account for only small quantities 
of the total trait variance). Such alleles are unlikely to have major 
effects on the genes in which they lie and thus are unlikely to be 
obviously functional (unlike the rare mutations that account for 
rare, strongly genetic diseases like cystic fibrosis or Huntington’s 
disease). Thus, the absence of obvious functional significance does 
not mean that a variant can be assumed NOT to impact the trait. 
Knowing whether an associated variant is causal takes considerable 
additional testing, and often claims of functionality are controver-
sial and contradictory.
the current stAte of reseArch At the InterfAce of 
GenetIcs And socIAl scIence
So why do developmental scientists need to understand concepts 
such as recombination and LD? Most developmental scientists 
will never conduct a linkage study and may never run a genome-
wide association studies (GWAS; though the latter is becoming 
increasingly unlikely due to falling genotype costs, as detailed 
further in section “What Should We Be Doing?”). Not every sci-
entist interested in genetic influence needs to be engaged in gene 
finding studies. However, there are still tremendous contribu-
tions that developmental scientists can make to understanding 
how genetic influences impact behavior. Most gene identification 
efforts continue to focus on adult psychiatric diagnoses, for many 
justifiable reasons, such as diagnostic reliability across the many 
sites necessary to obtain large enough numbers of individuals to 
have power to identify genes of small effect. But because the focus 
of gene identification is often with a static, distal outcome, this 
means that developmental scientists have much to offer in terms 
of further characterizing the risk associated with identified genes, 
studying how genetic risk unfolds across development, the medi-
ating processes by which risk unfolds, and what environments 
moderate risk among those carrying genetic susceptibilities. The 
importance of this line of research cannot be understated, and 
many projects of this sort are underway. However, the vast major-
ity of extant studies by developmental scientists continue to focus 
chromosomal region that may be involved in the outcome, whereas 
association analyses more narrowly implicate a specific gene or 
very small region.
There is another important distinction that must be made in 
association analyses, that of direct versus indirect association. 
This distinction is critical and, in the authors’ experience, often 
lost or ignored in studies incorporating genetic components 
in fields outside genetics. Direct association arises because the 
genetic variant that is associated with the disease/outcome has a 
functional consequence and is directly involved in susceptibility 
or outcome. Indirect association arises when a genetic variant is 
associated with disease/outcome because it is very close to the 
causal variant, but the associated variant is not itself causal in 
any way. Indirect association results from a phenomenon called 
linkage disequilibrium (LD). This refers to the fact that an indi-
vidual’s genotype at any one location is not independent of what 
their genotype will be at nearby locations in the genome. In other 
words, genetic variants that are nearby are often correlated. To the 
degree that two variants are correlated, knowing one’s genotype at 
one location also tells you something, albeit probabilistic, about 
what their genotype will be at the other location. This is because 
any time a mutation (a new variant in the human genome) occurs, 
it occurs on a specific chromosome background. Thus, at the 
time it occurs the new variant is perfectly correlated with all the 
other variants that exist on that chromosome. As the chromo-
some containing the mutation is transmitted to offspring across 
several generations, recombination will cause alleles at marker 
loci that are further from the mutation to be interchanged. This 
is because genetic variants that are further apart are more likely 
to be broken up due to recombination events. Genetic variants 
that are closer together are far less likely to have a recombination 
occur between them, leading to a higher correlation between the 
alleles at those nearby marker locations. Accordingly, the associ-
ated genetic background surrounding the mutation will become 
progressively smaller (Figure 2). In general, the closer the marker 
is to the novel variant, the stronger the LD will be (Jorde, 1995), 
Figure 1 | Allele frequency differences between cases and controls as 
defined by the liability threshold model. The white circles refer to the null 
allele, and the red circles refer to the risk (‘B’) allele. The cases are above the 
threshold for disease on the liability distribution and are more likely to carry 
the risk allele than the controls.
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the common patterns of human DNA sequence variation. With 
data from the HapMap project, we now know something about 
the LD structure (i.e., correlation pattern across alleles) for most 
genes in the human genome (Manolio et al., 2008). Further, there 
are many polymorphic markers available across most genes of 
interest. It is possible that multiple polymorphic sites exist in 
a gene that lead to differential function of that gene and con-
tribute to differential susceptibility to an outcome (McClellan 
and King, 2010). This is already well-known in Mendelian traits, 
where >1000 different mutations have been identified in the gene 
causing cystic fibrosis.
We illustrate the importance of genetic coverage using the exam-
ple of the Taq1A allele. This polymorphism was originally thought 
to be in the DRD2 gene, and has an extensive literature of reported 
associations (and failures to find association) with a number of 
phenotypes related to substance use, smoking, and a variety of 
other phenotypes related to impulsivity (Noble, 2000; Dick et al., 
2007c). Figure 3 shows a screenshot of output from the program 
Haploview (Barrett et al., 2005), which uses freely available data 
from the HapMap project to illustrate the LD structure of the chro-
mosomal region surrounding the DRD2 gene. Along the top of the 
figure is the base pair position of the chromosomal region, as listed in 
kilobases (i.e., 1000 nucleotide bases) to give an idea of scale. Directly 
underneath, the triangles indicate SNPs that were genotyped in the 
samples on which the Haploview data is based. The SNP highlighted 
in green is the rs1800497 marker commonly referred to as DRD2 
Taq1A. Beneath the SNPs, the genes in the region are listed. The 
length of the line reflects the length of the gene. One will note that 
the Taq1A allele is actually located in a small gene next to DRD2 
on a small number of purportedly functional polymorphisms from 
a small handful of genes. The literature is dominated by stud-
ies of purportedly functional polymorphisms in the serotonin 
 transporter gene (5HTTLPR), the monoamine oxidase A gene 
(MAOA-LPR), and the dopaminergic receptor gene DRD2 and 
adjacent region (TaqI A). It is nearly impossible to believe that, 
with nearly 4.5 million validated polymorphic positions currently 
identified in the human genome, those can be the only ones of 
interest for developmental science! Rather, these polymorphisms 
rose to prominence based largely on chance – they were poly-
morphisms discovered early with preliminary data suggesting 
that they altered function in candidate genes thought to be of 
interest for relevant behavioral phenotypes. It is certainly not our 
intention to argue that these genes are not of potential relevance, 
rather, we argue that with everything we now know about genetics, 
focusing only on these genes, and only on these widely studied 
polymorphisms within these genes, does not take advantage of 
the progress that has occurred in the field of genetics.
WhAt should We Be doInG?
Genotyping a single marker in a gene of interest no longer 
reflects current practice in genetics. The field of genetics has 
been revolutionized by the discovery and mapping of genetic 
markers across the human genome. In October of 2002, the 
International HapMap Project1 was initiated as a collaboration 
among scientists across multiple countries with the goal of 
developing a haplotype map of the human genome to describe 
Figure 2 | The preservation of linkage disequilibrium (LD) through mutation and subsequent recombination in the human genome. At the time the 
mutation occurs it is in LD with the genetic background of the chromosome. Recombination changes the genetic background as variation is introduced until only the 
DNA sequence very near the mutation remains in LD.
1www.hapmap.org
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mother as a child, and then using the results from that variable to 
make conclusions about whether the home environment played a role 
in the outcome of interest. A developmental scientist would rightly 
argue that such an analysis was at best naïve, and at worst, close to 
meaningless, and geneticists have ignored much of the literature 
on genetic associations deriving from the labs of social scientists 
for similar reasons.
In the same way that developmental scientists pay careful atten-
tion to the measurement of their outcomes of interest and potential 
environmental factors of relevance, the same care must be taken 
in characterizing genes of interest when research programs are 
expanded in this direction. The genetics research being carried 
out by developmental scientists should be of the same caliber as 
that being conducted in other areas of genetics, and it must keep 
up with the rapid advances going on in that field. Otherwise it 
will not be taken seriously. This does not mean that all develop-
mental scientists need to be “gene-finders” or to carry out GWAS. 
But it does mean that anyone involved in this kind of research 
should understand the complexities of studying genetics and be 
connected to the latest developments in genetics. Because of the 
rapid pace at which the field of genetics moves, this necessitates 
having collaborators who are tied more centrally to the world of 
genetics, and/or (for the younger generation of social scientists 
with interest in this area) to obtain focused training in genetics, 
ideally through a post-doctoral training experience. With ∼25,000 
genes in the human genome2, thousands of genetic association 
papers published, and GWAS papers being turned out every day, 
it impossible to believe that the handful of “usual suspects” are 
the only genes of interest for developmental outcomes. As large-
scale gene finding studies continue to report associations with 
called ANKK1. It is not located in DRD2 despite the large literature 
making claims about whether DRD2 was involved in many different 
phenotypes of interest based on genotyping at this marker. Below 
the genes is the LD plot, where shading indicates the degree of cor-
relation between markers (shown here as the small hash marks at 
the top of the figure) as measured by D’ (Hedrick and Kumar, 2001), 
with darker red shading indicating higher correlations; blue or white 
shading indicates the markers are unlinked or uncorrelated. What 
stands out is the block-like correlational structure, yielding inverted 
red triangles (i.e., “blocks”) comprised of groups of SNPs where 
there is high LD across that group of SNPs and low LD with sur-
rounding SNPs located outside the block. This block-like structure 
is observed throughout the genome (Gabriel et al., 2002). Knowing 
the correlational pattern is critical for the selection of markers and 
the interpretation of genetic association results. For example, DRD2 
spans at least two blocks on the attached figure. If different studies 
genotyped SNPs from different blocks, they could reach different 
conclusions about whether “DRD2 was associated” with outcome, 
depending on the location of the marker they chose and where the 
actual associated SNP was. Further, also note that the LD block that 
contains Taq1A spans the genes DRD2, ANKK1, and TTC12. This 
makes it very difficult to know which gene is actually important for 
an observed association, since the correlational structure means that 
a signal could originate from any gene in the correlated set (or LD 
block). More extensive genotyping across these genes, and the other 
gene located very nearby, NCAM1, has suggested that the association 
with substance use phenotypes extends to multiple genes in this 
region This underscores the necessity of understanding genomic 
structure in order to evaluate the role of hypothesized genes of 
interest. In the field of genetics, we would never test a single marker 
in a gene in order to make conclusions about the relevance of that 
gene for a given genotype. It would be the equivalent of asking a 
single question about whether a participant got along with his/her 
Figure 3 | Screenshot from Haploview (Barrett et al., 2005) showing the linkage disequilibrium structure surrounding the DrD2 gene.
2http://www.ornl.gov/sci/techresources/human_genome/faq/genenumber.shtml
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So which strategy is best? Candidate gene or GWAS? This ques-
tion is frequently posed by developmental scientists aiming to add 
genetic components to their studies (or submitting grants to do 
so for NIH review!). There is no easy answer. Most developmental 
scientists are not trying to discover new genes, as is generally the 
goal of GWAS. Thus, a more targeted candidate gene approach that 
aims to characterize risk processes and/or trajectories associated 
with identified genes is reasonable. However, we strongly recom-
mend that this targeted approach is not restricted to the “usual 
suspects,” but rather, draws from the broader literature of genetic 
findings for the phenotype of relevance, and ideally, includes col-
laborators from large-scale gene identification projects in relevant 
fields, in order to take advantage of new findings emerging in the 
area. Further, with all the knowledge we now possess about LD 
structure, researchers should use this information to genotype 
markers that capture genetic variation across the gene of interest, 
not limit their study to a single marker or polymorphism (except 
in strongly justified situations, such as where previous studies that 
have done exhaustive genotyping consistently implicate a particu-
lar marker or region of the gene). If a researcher is interested in 
understanding whether a particular gene is involved in a given 
outcome, (s)he should do a thorough job of characterizing the 
genetic variation across that gene. However, issues associated with 
multiple testing will need to be considered when analyzing the 
data, as discussed below.
The decision between candidate gene and GWAS is complicated 
by the logistics of genotyping. Genotyping is far more efficient 
and low cost when conducted on a large scale. Accordingly, the 
cost per genotype falls exponentially as the number of genotypes 
increases. High throughput genotyping using GWAS arrays is 1000 
times more cost-efficient than small scale genotyping. Thus, even 
if a social scientist has no interest in analyzing all 1 million mark-
ers across the genome, it may be more cost-efficient to genotype 
a GWAS chip on all participants, so that genotypes are available 
across the a priori genes of interest, as well as for future genes of 
interest that may emerge. This also facilitates collaborations and 
attempts at replication, since genes of interest from different groups 
will already be available in the proverbial “GWAS bank.” For this 
reason, it may be reasonable and cost-efficient to genotype a GWAS 
chip, even if a more targeted candidate gene strategy is proposed. 
Currently, GWAS chips cost approximately $200 to purchase and 
$100 to process, which may still make them out of reach for many 
social science projects where genotyping is not the primary focus. 
However, as costs continue to drop, the cost-benefit ratio may shift 
in favor of running GWAS chips. There are also custom chips avail-
able, which may provide an interim compromise of genotyping 
on a larger scale and covering far more candidate genes in a more 
cost-efficient manner than genotyping only a few candidates. But 
this still requires the selection of candidate genes, and does not 
have the advantage of genotyping across the genome for future 
collaborative purposes.
next-GenerAtIon sequencInG
There is mounting evidence that some proportion of risk for a 
variety of common traits is due to rare, possibly more deleterious 
genetic variation. This is in contrast to the predominant viewpoint 
of the past several years in which common complex phenotypes 
new and novel genes of interest, these genes too deserve further 
study by developmental scientist to delineate the trajectories of 
risk  associated with these genes.
study desIGn: cAndIdAte Gene? GWAs? sequencInG?
The two primary association strategies currently employed 
are  candidate gene studies and GWAS. Candidate gene studies 
are driven by theory and focus on a specific gene because it is 
believed to be involved in the underlying biology associated with 
the behavior/disorder. The primary drawback to the candidate 
gene approach is that it is limited by our knowledge of etiologi-
cal processes, which is often very incomplete when it comes to 
psychiatric disorders and related behavioral outcomes. Candidate 
gene research fell out of favor with the advent of GWAS. The pri-
mary advantage of GWAS is that this approach is not limited by 
our knowledge of the underlying biology of behavioral disorders; 
that is, GWAS is an atheoretical approach and since the whole 
genome is assayed for effects, there is no selection bias. GWAS 
have the ability to find novel susceptibility genes that, in turn, 
can help advance our understanding of the etiology of the trait 
or disorder. Several different companies now offer GWAS “chips” 
that have a predefined set of genetic markers that cover genetic 
variation across the genome. Although the exact markers on the 
chips vary and companies have used different approaches to select 
markers, the basic idea is to cover genetic variation across the 
genome using knowledge about LD patterns (as described above). 
Through the known LD in the genome, chips with ∼1 million 
markers arrayed on them can track genetic variation down to 
minor allele frequencies of about 5%, while larger arrays of ∼2.5 
million markers can track alleles down to about 1% frequency in 
the population. In this way, there is fairly good coverage of most 
genes across the genome, as well as intergenic regions (which may 
contain regulatory elements or have other unknown functions). 
Another advantage of GWAS is that it provides a built in method 
to test for genetic background and control for potential population 
stratification. Population stratification can occur when there are 
different background allele frequencies and different trait means 
or prevalences as a function of population membership. In GWAS, 
having such a large number of markers tested across the genome 
provides a way to genetically determine ethnic background, so 
that this information can be used as a covariate in the association 
analyses, alleviating potential population stratification concerns.
There are caveats to GWAS. The most widely used platforms do 
not do a good job of covering rare variants (genetic markers with 
minor allele frequencies less than 1%). In addition, LD patterns 
are population specific. To address this issue, the HapMap project 
analyzed DNA from populations with African, Asian, and European 
ancestry. However, GWAS platforms differ in how well they cover 
genetic variation for different populations, so this must be consid-
ered when analyzing any particular gene (or the genome) because 
it can affect how good the coverage is in your sample depending 
on its racial composition. GWAS are also complicated by the fact 
that multiple testing corrections must be applied when conducting 
such an incredibly large number of tests (e.g., for 1 million mark-
ers across the genome), and there is differing opinion about how 
best to do that (van den Oord, 2007). This issue will be discussed 
further in section “Analyzing Genetic Data.”
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have been reported, these samples generally are not of the qual-
ity needed for the most intensive contemporary applications, like 
GWAS and sequencing. The enhanced sample quality requirements 
for these applications argues strongly for the use of higher quality 
sampling methods.
Collection of DNA from saliva samples is an intermediate cost 
sampling method ($15–20 per subject) that can still be inexpen-
sively posted to participants. This approach yields high quality DNA 
suitable for most applications. The saliva samples themselves are 
stable for at room temperature for 6–12 months. Both buccal swab 
and saliva sampling have the advantage of being non-invasive which 
increases participation rates.
Next in terms of rising cost ($100 per participant) and quality is 
to sample whole blood. The total yield of DNA from one such sam-
ple can last a laboratory for many years, even with fairly intensive 
use (i.e., lots of genotyping). Most critically, blood samples are the 
only sample source which can, if the additional costs are available, 
be transformed to yield immortalized cell lines. These cell lines 
provide a long-term source of DNA, RNA, protein or cell lysates 
for future work. They also require regular maintenance by skilled 
staff. Although this final step means the samples from a project will 
last for as long as they are properly maintained, it is probably not 
viable for most social scientists unless they have access to either a 
core facility or a collaborating lab.
AnAlyzInG GenetIc dAtA
Beyond standard quality control protocols administered in the wet 
lab, genotypic data requires the same sort of pre-analysis cleaning 
procedures that social scientists would apply to any phenotypic 
or environmental data. For example, one would want to assess 
whether willingness to provide a DNA sample is systematically 
associated with the non-genetic variables of interest (i.e., are the 
participants who gave DNA different in any way). Likewise, it is 
important to verify that the values corresponding to each of the 
alleles reflect viable nucleotide bases; that is, at a locus polymorphic 
for adenine and guanine, none of the study participants should 
have a value representing cytosine. In addition to these generic 
practices, genotypic data should also be screened to determine 
whether the observed distribution of genotypes differs from that 
which is expected, given the allelic frequencies observed within a 
given population – in other words, do the genotypes in your sample 
deviate from Hardy–Weinberg equilibrium (HWE)? In the simple 
case of a bi-allelic variant, like a SNP, the expected distribution of 
genotypes is easily derived via a Punnett square, and HWE can be 
tested using Pearson’s Chi-square. In contrast, examining polymor-
phisms with more variants and/or in smaller samples might require 
use of Fisher’s exact test. Moreover, departures from HWE can result 
from a variety of population level disturbances that are out of the 
researchers’ control (assortative mating, selection, mutation, and 
migration). It should be noted, however, that studies which over-
sample for specific traits or disorders (e.g., case–control designs) 
will also, to the extent that they examine genetic variants associated 
with those characteristics, yield deviations from HWE.
Once the data have been cleaned and deemed ready for use, 
genotypes can, for all practical purposes, be incorporated into 
standard analytic frameworks (e.g., regression-based analyses). 
However, a critical point is that, unlike many variables that are 
were thought to result from fairly common genetic polymorphisms; 
this was referred to as the common disease – common variant 
hypothesis. The ability to consider the impact of rare variants has 
been aided by technological developments. The single most impor-
tant technological development in studies of genetic  disease in 
recent years is the revolutionary change in the way human sequence 
data are generated. Whereas genetic techniques were previously 
limited to genotyping specific markers, these new methodologies 
make it possible to generate “sequence” data, in other words, the 
actual sequence of nucleotides that make up an individual’s DNA. 
Not surprisingly, this approach is fundamentally changing the 
way genetic disease studies are pursued. Moreover, despite the fact 
that sequencing an entire genome is still prohibitively expensive 
(i.e., ∼$16,000 per individual), whole genome sequencing is set to 
become the standard as costs continue to fall with increasing instru-
ment output. In the meantime, intermediate sequencing techniques 
are being pursued, such as sequencing only the exome, the set of all 
exons that code for proteins (which constitutes ∼34 million bases, 
or ∼1% of the total sequence).
A more general targeted sequencing approach focuses on genes 
or regions well-supported (e.g., by GWAS) for involvement in a trait 
or disease, but is not generally limited to the coding sequence within 
the target region. Well-supported regions have been observed in a 
variety of important traits like type 2 diabetes and Crohn’s disease, 
and to a lesser extent in schizophrenia. In traits for which extensive 
sequence data have already been generated, excess rare variation has 
in fact been detected in cases compared to controls, or in individuals 
at different points on a quantitative trait distribution. This provides 
support for the idea that there may be very rare genetic variants 
that affect common phenotypes, like the type social scientists are 
interested in.
Overall, however, these technologies are in early stages of gen-
eral application to human diseases, with a number of technical 
and analytic issues still needing to be worked out. As such, the 
kinds of variation contributing to individual differences in vari-
ables of interest to the social scientist remain poorly understood 
and sequencing designs are generally not appropriate currently 
for most such studies, unless there is substantial evidence of the 
kind detailed above supporting strong genetic effects or strong 
target regions. But this next generation of genetic techniques are 
changing the way we think about the many types of genetic varia-
tion that can affect behavior, so we include mention of them here 
to make the social scientist aware where the field of genetics is 
currently headed.
other consIderAtIons for the socIAl scIentIst
dIfferent Methods of collectInG dnA
DNA collection methods are distinguished primarily on the basis 
of cost and sample quality, with a generally inverse relationship 
between the two. The cheapest way of obtaining DNA samples 
is to use buccal swabs, brushes or cotton buds that collect cells 
from the inside of the cheek. These have a long shelf life and can 
be mailed in large numbers very cheaply. However, they have the 
distinct disadvantage of yielding the lowest quality, most degraded 
genomic DNA because the collected cells have been sloughed off 
by the cheek epithelium and the DNA has been partially degraded 
by natural processes. Although GWAS using buccal swab samples 
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ments of the research design including, but not limited to, the cod-
ing of phenotype (e.g., case–control versus continuous outcome) 
and genotype (e.g., additive versus dominant or recessive modes 
of inheritance), minor allele frequency (MAF), type I error rate, 
and the hypothesis under consideration (i.e., genetic main effect, 
gene–environment interaction, or even gene–gene interaction). To 
illustrate, let us consider how several of these factors might influ-
ence the sample size required to replicate the effects of a putative 
SNP with association with major depressive disorder, a phenotype 
of interest to many social scientists which affects ∼6.7% of adults 
in the U.S. population in a given year (Kessler et al., 2005). We will 
begin by setting our minimum acceptable thresholds for power at 
0.80 and type I error rate at 0.05. Given the dichotomous nature of 
the phenotype, we will further assume a 1:1 matched case–control 
design, and start with a baseline model for a genotypic main effect 
that reflects an additive mode of inheritance, a MAF of 0.1, and an 
OR of 1.15. To detect this effect under the circumstances described 
above would require 4261 participants, half cases and half con-
trols. Holding all else constant, hypothesizing a dominant mode of 
inheritance would require 5037 participants, whereas reducing the 
frequency of the risk allele by half (i.e., 0.005) would require 8021 
participants. Similarly, to be able to detect an effect that is somewhat 
smaller in magnitude (e.g., OR = 1.1), though still very much in 
line with those frequently reported in the literature, would require 
9296 participants. In contrast, to detect an effect of that same SNP 
(MAF = 0.1) accounting for 1% of the variability in a continuously 
distributed indicator of depression within a community sample 
would only require 781 individuals total. Thus, when estimating 
power for relatively straightforward designs, we suggest that social 
scientists utilize some of the free power calculation software that 
is available on-line (e.g., Quanto3).
Finally, a central issue in the field of genetic association studies 
is the lack of consensus on how to deal with multiple, non-inde-
pendent analyses. Because there is likely to be LD between many of 
the individual markers examined, a standard Bonferroni correction 
(which assumes complete independence) could mask the existence 
of some, if not many important associations. As such, statistical 
geneticists have developed a number of alternative strategies for 
taking these dependencies into consideration (see Ziegler et al., 
2008 for a recent review). One fairly common approach is to use 
the existing LD structure to estimate the number of “independent” 
effects represented by a set of SNPs (Nyholt, 2004). That is, the 
estimated number of effects is used as the denominator in a modi-
fied Bonferroni correction. A software package for this purpose, 
SNPSpD, is freely available on-line4. Still, since there is no agreed 
upon gold standard for dealing with multiple testing, it is probably 
most important for researchers to present sufficient information 
for a diverse audience to be able to assess the approach taken, and 
the interpretation proffered.
AddItIonAl chAllenGes And consIderAtIons
This review has largely focused on basic genetic concepts that 
are critical for social scientists to understand when incorporating 
genetic components into their research. But we would be remiss 
modeled by social scientists, how a genotype is coded infers 
something about the biological risk (i.e., the underlying genetic 
model). For example, genetic markers may influence a particular 
phenotype in a simple linear manner, where each copy of a “risk” 
allele confers an equivalent cumulative (i.e., additive) effect. In 
this sense,  individuals with two copies of the allele at a given SNP 
are presumed to have twice the risk of those with single copy, rela-
tive to those with 0 copies. Alternately, the influence of genotype 
might also function in a dominant (one or more copies of the risk 
allele is sufficient to produce the outcomes, with an equivalent 
phenotype across those with one or two copies of the risk allele) 
or recessive (two copies of the risk allele are needed before the 
phenotype is manifest, with individuals having 0 or 1 copy showing 
an equivalent phenotype) manner. These genetic models would 
necessitate a different coding scheme for the marker. Atheoretical 
approaches like GWAS traditionally model additive genetic influ-
ences, such that each copy of a specific variant is assumed to have 
the same magnitude of effect. In doing so, genotypes (e.g., AA/
AG/GG) are coded 0, 1, or 2, with respect to a reference variant (in 
this case, G). In the absence of biologically plausible hypotheses 
and/or robust empirical evidence to the contrary, the analysis of 
candidate genes should generally start with an additive model. It 
would not be advisable, for instance, to arbitrarily collapse across 
genotypes solely for the purpose of increasing the statistical power 
of a model to detect significant associations. However, with the right 
justification, alternative coding schemes can be introduced. For 
example, if the literature on a specific SNP strongly suggests that 
the mere presence of a particular allele confers risk, the genotype 
may be coded to reflect the dominant influence of that allele (i.e., 
absence versus presence, irrespective of the number of copies). By 
contrast, researchers interested in determining the extent to which 
an allele operates in a non-additive manner could pair the addi-
tive term described above with a term differentiating heterozygous 
from homozygous genotypes, though this model would require an 
additional degree of freedom. What’s most important to remember 
is that these decisions should be based on prior research findings, 
biologically based theory, and in consultation with individuals who 
have formal training in genetics. Moreover, regardless of how the 
data get coded, the degree of association between the outcome of 
interest and a set of genetic variants should roughly map onto the 
pattern of LD across those variants. That is to say, if you are test-
ing a group of highly correlated SNPs, you would expect a similar 
association pattern across them. In contrast, if SNPs are located in 
different LD blocks (i.e., have a low correlation), it would not be 
concerning if they yielded different association results.
Two remaining points have to do with the aforementioned issues 
of statistical power and multiple testing. Statistical power should 
be the foremost consideration of any proposed genetic association 
study, with sample sizes assembled accordingly. Although power 
derived from large samples is necessary for the analysis of com-
plete genome-wide data because of the number of individual tests 
performed, it is also worth noting that many studies of candidate 
genes are also underpowered to detect effects of the sizes cur-
rently expected on the basis of GWAS data from other behavioral 
or psychiatric phenotypes (allelic odds ratios [OR] in the range of 
1.1–1.15). As such, social scientists should be aware that statistical 
power in genetic association studies is a function of several ele-
3http://hydra.usc.edu/gxe/
4http://gump.qimr.edu.au/general/daleN/SNPSpD/
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DNA transcription. One epigenetic process that affects transcrip-
tion binding is DNA methylation. DNA methylation involves the 
addition of a methyl group (CH
3
) onto a cytosine (one of the four 
base pairs that make up DNA). This leads to gene silencing because 
methylated DNA hinders the binding of transcription factors. A 
second major regulatory mechanism is related to the configuration 
of DNA. DNA is wrapped around clusters of histone proteins to 
form nucleosomes. Together the nucleosomes of DNA and histone 
are organized into chromatin. When the chromatin is tightly con-
densed, it is difficult for transcription factors to reach the DNA, and 
the gene is silenced. In contrast, when the chromatin is opened, the 
gene can be activated and expressed. Accordingly, modifications to 
the histone proteins that form the core of the nucleosome can affect 
the initiation of transcription by affecting how readily transcription 
factors can access the DNA and bind to their appropriate sequence.
Epigenetics has caused a great deal of excitement in social sci-
ence, as it provides a potential mechanism for how the environment 
can “get under the skin.” It provides a biological process by which 
exposure to environmental events could affect outcome and could 
lead to long-term enduring changes. Elegant work in animal models 
suggests that epigenetic changes may be involved in the associations 
between early environmental manipulations and long-term effects 
that persist into adulthood, and we refer the interested reader to 
reviews by Meaney and colleagues on this topic (Meaney, 2010; 
Zhang and Meaney, 2010). At this time, epigenetic processes are 
not well-understood. As mentioned previously, the mechanisms by 
which identified sequence variants in the genome affect outcome are 
also poorly understood at this time. It is possible that some of these 
variants may act by altering the likelihood of epigenetic modifica-
tion, providing an explanation for why some individuals are more 
influenced by environmental events. Future research is necessary to 
better understand how these genetic phenomena interrelate.
An exAMple of reseArch At the IntersectIon of 
GenetIcs And socIAl scIence
The challenges inherent in studying genetics should not discour-
age the social scientist from embarking on this area of research, as 
the potential for moving both fields forward by taking advantage of 
the knowledge base of each is too great. Our experience with these 
interdisciplinary collaborations is that they end up being rewarding, 
educational, and beneficial to all involved – and that they result in 
exciting research advances! As one example, some years back, the 
Principle Investigators on the Child Development project (Drs. Jack 
Bates, Ken Dodge, and Greg Pettit) approached Danielle M. Dick 
about adding a genetic component to their on-going longitudinal 
study of >500 children, first assessed as they entered kindergarten, 
with >20 years of developmental data. The project’s guiding model 
of developmental process was that children’s biological dispositions, 
cultural contexts, life experiences, and characteristic social cognitions 
transactionally combine to influence a variety of behavioral out-
comes, making it a natural extension of the project to add genotypic 
data. The rich, longitudinal assessments of the Child Development 
Project (CDP) offered special advantages for studying the pathways 
by which genetic factors influence behavioral development. One of 
the first genes we genotyped was GABRA2, a gene originally identified 
as associated with alcohol dependence in the collaborative study of 
the genetics of alcoholism (Edenberg et al., 2004), the largest gene 
to leave the reader with the impression that teaming up with 
geneticists will provide clear answers about the way forward. The 
rapidly changing landscape in the field of genetics and constant 
advances in the tools used for gene finding have raised nearly as 
many questions as they have provided answers. GWAS have not 
been wildly successful in psychiatric and behavioral phenotypes, 
raising question about why this is the case, as other common com-
plex, polygenic disorders have enjoyed greater success (e.g., with 
GWAS mapping many novel loci for Crohn’s disease and type 2 
diabetes; McCarthy et al., 2008). However, even in disorders that 
have enjoyed more success in mapping risk loci, the variants that 
have been identified only account for a very small fraction of the 
heritability. This has been called the “missing heritability problem” 
(Manolio et al., 2009), and several potential explanations have been 
put forth for this phenomenon, including the potential importance 
of rare variants and/or structural variants (genomic changes such 
as insertions, deletions, inversions, and translocations of stretches 
of genetic material), neither of which are well captured by current 
GWAS platforms. In addition, there is the possibility of gene–
gene and/or gene–environment interactions. The very small effect 
sizes associated with identified variants have led to the need for 
increasingly large consortia and meta-analyses to have reasonable 
power to detect these small effects; for example, a recent GWAS of 
body mass index analyzed data from nearly 250,000 individuals 
(Speliotes et al., 2010)! As studies are combined for these large 
meta-analyses, the ability to analyze more refined phenotypes is 
usually compromised, as different assessments often have been 
used across different studies. One can imagine that the additional 
layer of trying to find common environmental measures that have 
been assessed across studies to incorporate gene–environment 
interaction into these efforts becomes formidable. I often hear 
social scientists chiding geneticists for “ignoring” the environ-
ment; hopefully the reader will now have better appreciation of 
the daunting challenges that are being faced by geneticists and 
why incorporating environmental information into gene finding 
efforts is yet another layer of complexity on an already challenging 
problem. Of course one could argue that taking into account envi-
ronmental information might increase the effect size associated 
with any one locus and reduce the number of participants that 
are required, but this debate is beyond the scope of this paper. The 
take home message is that a degree of patience and appreciation 
for the challenges faced by each respective field is critical, as social 
scientists begin to enter the world of genetics, and geneticists try 
to incorporate aspects of social science.
Where does epIGenetIcs fIt Into thIs dIscussIon?
Most of this review has focused on changes to the DNA sequence, 
such as SNPs and copy number variants. The emerging field of epi-
genetics assesses the impact of chemical modification of the DNA 
bases rather than changes to the sequence itself. To better under-
stand this concept, one needs to understand that the expression of 
a gene is influenced by transcription factors, which bind to specific 
sequences of DNA. It is through the binding of transcription factors 
that genes can be turned on or off. Epigenetic mechanisms involve 
changes to how readily transcription factors can access the DNA. 
Several different types of epigenetic changes are known to exist 
that involve different types of chemical changes that can regulate 
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was supported: the association between CHRM2 and externalizing 
behavior was exacerbated among those exposed to higher levels of 
peer group antisocial behavior (Latendresse et al., 2011). These stud-
ies illustrate how genotyping genes coming out of gene identifica-
tion projects in longitudinal, developmental samples can help us 
understand the pathways of risk associated with those genes. The 
DNAs for the child development project are currently in Brien Riley’s 
laboratory, making it possible to genotype novel genes coming out of 
the gene identification projects on which Danielle M. Dick and Brien 
Riley are involved in this developmental sample. Taking genes that are 
identified in highly selected, affected populations, and characterizing 
their risk in community-based samples, across development and in 
conjunction with experiential and other individual risk and protec-
tive factors, will be critical to potentially use genetic information in 
the future to inform prevention and intervention efforts.
conclusIons
The integration of genetics into developmental projects and other 
studies conducted by social scientists has great potential to enhance 
our understanding of the mediating pathways and mechanisms by 
which genetic susceptibility may (or may not) translate into risk 
behavior. However, in order to realize this potential, genetics research 
conducted by developmental, social scientists must reflect the cur-
rent “state-of-the-science” practices from the field of genetics. Close 
collaborations between social scientists and geneticists are likely to 
be necessary to achieve this and to be of mutual benefit to both fields.
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identification project currently in existence for alcohol dependence, 
on which Danielle M. Dick is a collaborator. The association with 
adult alcohol dependence was subsequently replicated in many 
independent samples from around the world (Enoch, 2008). Based 
on the twin literature indicating that childhood behavior problems 
and adult alcohol dependence overlap largely due to shared genetic 
factors (Slutske et al., 1998), we hypothesized that GABRA2 would 
be associated with behavior problems at earlier stages of develop-
ment. We also hypothesized that the association between the gene 
and behavior problems would be moderated by parental monitor-
ing, based on our work in the Finnish twin studies showing that 
parental monitoring moderates the importance of genetic effects 
(Dick et al., 2007b). These hypotheses were supported: GABRA2 was 
associated with trajectories of externalizing behavior across adoles-
cence, with the genotype previously associated with adult alcohol 
dependence in COGA associated with persistent, elevated levels of 
behavior problems across adolescence in CDP. Furthermore, this 
association was moderated by parental monitoring: the association 
between the genotype and behavior problems was stronger under 
conditions of lower parental monitoring, attenuated under higher 
parental monitoring (Dick et al., 2009). A second set of analyses 
produced similarly exciting results in the sample. CHRM2 is another 
gene associated with alcohol dependence in the COGA project (Wang 
et al., 2004) and subsequently replicated in an independent sample 
(Luo et al., 2005), We genotyped markers across this gene in CDP, 
and, parallel to GABRA2, found associations with trajectories of 
externalizing behavior. Further, we tested whether this association 
was moderated by peer group antisocial behavior based on previous 
twin studies demonstrating that genetic influences on substance use 
and problem behavior are enhanced as individuals are exposed to 
higher levels of peer antisocial behavior and substance use (Button 
et al., 2007; Dick et al., 2007a; Harden et al., 2008). Our hypothesis 
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